Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 9—September 2025
Research Letter
Human Babesiosis Caused by Babesia venatorum, Russia, 2024
Table
Characteristics of case-patient in study of human babesiosis caused by Babesia venatorum, Russia, 2024*
Tests performed |
Results by date |
||||||
---|---|---|---|---|---|---|---|
Oct 3 |
Oct 7 |
Oct 10 |
Oct 14 |
Oct 22 |
Nov 8 |
Reference range |
|
Hematologic parameters | |||||||
Hemoglobin, g/dL | 11.2 | 9.3 | 11.6 | 11.6 | 12.0 | 15.5 | 11.7–18.0 |
Hematocrit, % | 32.0 | 27.0 | 34.8 | 32.7 | 36.1 | 46.8 | 35–52 |
Erythrocytes, ×1012 cells/L | 3.48 | 3.01 | 3.96 | 3.51 | 3.85 | 5.1 | 3.8–6.1 |
RBCN, L | 10:100 | 4:100 | 7:100 | NA | NA | NA | 0:100 |
Platelets, ×109/L | 21 | 127 | 154 | 346 | 230 | 217 | 150–450 |
Leukocytes, ×109 cells/L | 4.8 | 8.3 | 7.8 | 5.7 | 9.1 | 10.4 | 4–11 |
Parasitemia level, %† |
2.43 |
2.91 |
1.56 |
0 |
0 |
0 |
0 |
Biochemistry | |||||||
Alanine aminotransferase, U/L | 7.4 | 22.0 | NA | 21.0 | 16.0 | NA | ≤40 |
Aspartate aminotransferase, U/L | 27.0 | 67.0 | NA | 25.0 | 30.0 | NA | ≤40 |
Total bilirubin, μmol/L | 84.9 | 38.1 | NA | 11.8 | 9.0 | NA | 3.1–16.9 |
C-reactive protein, mg/L | 1.3 | 0.7 | NA | 1.6 | 4.0 | NA | 0–0.5 |
Urea, μmol/L | na | 7.5 | NA | 3.3 | 6.0 | NA | 2.5–8.3 |
Creatinine, mcM/L | 97.0 | 91.0 | NA | 111.0 | 107.0 | NA | 53–106 |
Glucose, μmol/L | 25.6 | 14.6 | NA | 8.4 | 7.5 | NA | 3.3–5.5 |
Total protein, g/L | 56.0 | 55.0 | NA | 68.5 | 93.0 | NA | 62–81 |
*NA, not available; RBCN, red blood cell normoblasts. †Percentage of erythrocytes that were infected.
Page created: August 05, 2025
Page updated: August 19, 2025
Page reviewed: August 19, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.